Product logins

Find logins to all Clarivate products below.


Varicose Vein Treatment Devices | Market Insights | Europe | 2019

he European varicose vein treatment device market will be characterized by shift toward and a changing reimbursement landscape for endovenous ablation technologies, namely ERFA and ELA, which will compete with surgical stripping procedures through 2027. 

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for varicose vein treatment devices in Europe across a 10-year period.

Related Medtech Insights Reports

Report
Biosurgical Agents – Market Insights – Europe
The Europe biosurgical agent market will exhibit modest growth over the forecast period. This expansion will be fueled by a continued preference for biosurgical agents over alternative solutions,…
Report
Trauma Devices – Market Insights – Europe
Although financial constraints among European healthcare facilities and the rise of GPOs that will exert downward pressure on ASPs will limit the European trauma device market, favorable…
Report
Varicose Vein Treatment Devices – Market Insights – United States
The US varicose vein treatment device market will be driven by the continued shift toward minimally invasive procedures and the evolving reimbursement landscape supporting endovenous ablation and…
Report
Infusion Pumps – Market Insights – Europe
The European infusion pump demand will be underpinned by aging populations and rising chronic disease, while accelerating adoption of closed-loop, EHR-integrated smart pumps and growing demand of…
Report
Laparoscopic Devices – Market Insights – Europe
Laparoscopic procedure volumes in Europe will grow only modestly through 2034, with notable variation across procedure types. Bariatric and colorectal laparoscopic surgeries are expected to…